Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neoplasm with perivascular epithelioid cell differentiation, often associated with tuberous sclerosis. It is characterized by the presence of smooth muscle and epithelioid cells and by the proliferation of lymphatic vessels. Sites of involvement include the lymph nodes, lung, mediastinum, and retroperitoneum.
Biomarker and diagnostic research for lymphangiomyoma has been reported in the published literature.
13 clinical trials registered, 9 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and medical devices. Pipeline includes 1 PHASE3, 4 PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06405997](https://clinicaltrials.gov/study/NCT06405997) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC
The Genotype and Phenotype of Lymphangioleiomyomatosis |
— |
National Taiwan University Hospital |
RECRUITING |
[NCT01799538](https://clinicaltrials.gov/study/NCT01799538) | Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis | PHASE1 | National Heart, Lung, and Blood Institute (NHLBI) | RECRUITING |
[NCT01484236](https://clinicaltrials.gov/study/NCT01484236) | National Lymphangioleiomyomatosis Registry, France | — | Vincent COTTIN | RECRUITING |
[NCT05676099](https://clinicaltrials.gov/study/NCT05676099) | TSC Biosample Repository and Natural History Database | — | National Tuberous Sclerosis Association | RECRUITING |
[NCT02432560](https://clinicaltrials.gov/study/NCT02432560) | Safety and Durability of Sirolimus for Treatment of LAM | — | University of Cincinnati | RECRUITING |
98 publications have been identified in PubMed for lymphangiomyoma. Research spans Case Report / Case Series (22%), Basic Science / Preclinical (22%), and Review / Meta-Analysis (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 22 | 22% |
Laboratory research | 22 | 22% |
Research summaries | 17 | 17% |
Clinical study results | 12 | 12% |
Disease patterns and progression | 10 | 10% |
Testing and diagnosis research | 8 | 8% |
New treatment approaches | 4 | 4% |
Other research | 3 | 3% |
Clements D (2026). [PMID: 41381226](https://pubmed.ncbi.nlm.nih.gov/41381226/). *Eur Respir J*. [Basic Science / Preclinical]
Mukhitov AR (2026). [PMID: 40920984](https://pubmed.ncbi.nlm.nih.gov/40920984/). *American journal of respiratory cell and molecular biology*. [Clinical Trial Publication]
Bai W (2026). [PMID: 41559739](https://pubmed.ncbi.nlm.nih.gov/41559739/). *Orphanet journal of rare diseases*. [Diagnostic / Biomarker]
Johnson J (2026). [PMID: 41198176](https://pubmed.ncbi.nlm.nih.gov/41198176/). *Thorax*. [Case Report / Case Series]
Cheng CS (2026). [PMID: 41483917](https://pubmed.ncbi.nlm.nih.gov/41483917/). *Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases*. [Diagnostic / Biomarker]
Chen H (2026). [PMID: 41656758](https://pubmed.ncbi.nlm.nih.gov/41656758/). *The Journal of international medical research*. [Case Report / Case Series]
Szalai F (2026). [PMID: 41171076](https://pubmed.ncbi.nlm.nih.gov/41171076/). *Histopathology*. [Case Report / Case Series]
Gudi H (2026). [PMID: 41521085](https://pubmed.ncbi.nlm.nih.gov/41521085/). *Semin Roentgenol*. [Review / Meta-Analysis]
Gai Z (2026). [PMID: 41519401](https://pubmed.ncbi.nlm.nih.gov/41519401/). *Biochemical pharmacology*. [Review / Meta-Analysis]
Yang L (2026). [PMID: 41933736](https://pubmed.ncbi.nlm.nih.gov/41933736/). *Biochim Biophys Acta Mol Cell Res*. [Basic Science / Preclinical]